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ABSTRACT
Purpose. The study aimed to determine the extent of and factors influencing the
prescribing of injections for the treatment of mild/moderate community acquired
pneumonia (CAP) in Mongolia.
Methods. Questionnaires were developed and administered to medication providers
(34 Pharmacists, 27 pharmacy technicians) and prescribers (22 general doctors and
49 medical specialists) working in Mongolia.
Results. Cefalosporins were prescribed for patients with mild pneumonia and
doctors tended to prescribe injectable cefalosporins (cefazolin) rather than oral
dosage forms. This was supported by the questionnaire study with pharmacists
and pharmacy technicians. Additionally, 23 pharmacists and pharmacy technicians
indicated that OTC injectable cefalosporins (37.7%) and injectable aminopenicillins
(33,9%) were frequently sold by pharmacies for the treatment of mild/moderate CAP.
Doctors and particularly pharmacists in the questionnaire studies indicated choosing
an injection was to avoid non-compliance problems.
Conclusion. High levels of injectable prescribing of antibiotics were found in
non-hospitalized patients with CAP in Mongolia. This prevalence level indicated
that inappropriate injection prescribing is a public health hazard for Mongolia and
requires consideration by the appropriate authorities.
Subjects Global Health, Pharmacology, Public Health, Respiratory Medicine
Keywords Injections, Pneumonia, Prescribing, Dispensing, Parenteral medication, Developing
country, Mongolia
INTRODUCTION
Medicines are commonly administered by injection in healthcare settings for the
prevention, diagnosis, and treatment of various illnesses. Unsafe injection practices
including the re-use of equipment without sterilization has been associated with a wide
variety of procedures and settings and puts patients and healthcare providers at risk
How to cite this article Dorj et al. (2015), A questionnaire study of injections prescribed and dispensed for patients diagnosed with
mild/moderate community-acquired pneumonia in Mongolia. PeerJ 3:e1375; DOI 10.7717/peerj.1375
of infectious and non-infectious adverse events (World Health Organization, The SIGN
Alliance, 2001).
The Global Burden of Disease project (World Health Organization (WHO)) conducted
a literature review and found that the annual number of single injections administered
per person ranged from 1.7 to 11.3 per year (Hutin, Hauri & Armstrong, 2003). A
systematic review of studies from 13 developing countries regarding injection use and
safety reported that for eight of those countries, 25–96% of outpatient visits resulted in
at least one injection, and for five countries a majority of the administered injections was
unnecessary (Simonsen et al., 1999). An assessment of injection practices in Mongolia
showed a high injection frequency rate; reporting an average of 13 injections per person
per year amongst a small sample of 65 participants and the most common reason for an
injection was community-acquired pneumonia (CAP) (Logez et al., 2004).
CAP accounts for 95% of all pneumonia cases in the world among children aged less
than five years of age (Wardlaw, Johansson & Hodge, 2006). In a prospective study in five
countries of factors of CAP caused by bacteraemic pneumococcal disease, death rates
ranged from 6% in Canada to 20% in the USA, 13% in the UK and 8% in Sweden (Kalin
et al., 2000). The mortality rate from CAP for children aged less than five was 34.4% in
2011 in Mongolia and was the second most common reason for all hospitalizations in 2011
amongst children (46%) (Ariuntuya et al., 2011). The general consensus is that pneumonia
should be treated with antibiotics and for those with mild/moderate CAP oral administra-
tionis appropriate (World Health Organization, 2005; Antibiotic Expert Group, 2010).
The Mongolian standard treatment guidelines (STGs) for adult and paediatric patients
are available and widely accessible in the Mongolian language. For adult patients, the
STGs recommend oral amoxicillin (ampicillin) 500 mg every 6 h or erythromycin 500 mg
every 6 h (Batsereedene, Naidansuren & Oyunbileg, 2003). The treatment standard
for paediatric pneumonia is classified into infants and children aged up to five years
old. The STGs for infant patients diagnosed with mild/moderate CAP recommends
benzylpenicillin, aminoglycoside (gentamicin) injection. Treatment of children aged up to
five years old should include semi-synthetic penicillin (50 mg/kg/4 times) plus gentamicin
(7.5 mg/kg/once)-injection and other options include cephalosporin generations II–III. In
addition, any of the following could be prescribed for children aged up to five years can be
prescribed: salbutamol, euphyllin, epinephrine, prednisolone, dexamethasone, vitamin C,
A or E, if considered to be necessary.
The reasons for prescribing parenteral medications in developing countries include
socio-cultural, economic and structural factors. The belief in injections as a strong tool
for restoring and maintaining health is mutually supported by health professionals
and community members in many developing countries (Berild et al., 2002). Previous
studies have indicated poor knowledge of the associated risks and burden of unsafe and
unnecessary injection practices and easy access to parenteral medication contributes to the
popularity of injections in developing countries (Birungi, 1998; Lakshman & Nichter, 2000;
Reeler, 2000).
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OBJECTIVE
The study aimed to determine the extent of, and factors influencing the prescribing of
injections for the treatment of patients diagnosed with mild/moderate CAP in Mongolia.
MATERIALS AND METHODS
Two questionnaires were developed using a WHO/SIGN guide (Hulscher, Grol & van der
Meer, 2010; World Health Organization, The SIGN Alliance, 2001). This guide included
information relevant to investigation of injection practices, their determinants and their
consequences. In addition, face validation of both questionnaires was performed with
pharmacy academics and practitioners from Australia and Mongolia, to ensure the validity
of questions exploring doctors’ and pharmacist’s practises of prescribing, dispensing and
supplying injections for the treatment of CAP in Mongolia. Content validation was carried
out with three family group practitioners and two specialists practising in a conveniently
selected large central hospital (for the doctor questionnaire). The one for pharmacists and
pharmacy technicians was tested with two pharmacists and two pharmacy technicians
working in randomly selected pharmacies (representing the pharmacists). The purpose of
the piloting phase was to ensure that the questions were clear, and achieved the objectives
of the study. In addition, it was important that the instrument could be completed
in a reasonable amount of time. Following their feedback and discussion with local
professionals, the wording and order of some the questions were modified. The responses
collected during the pilot studies were not used for further analyses. Respondents could
choose more than one option in questions regarding the prescribing and dispensing
practice of antibiotics and non-antibiotics for the treatment of mild/moderate CAP.
Selection of study sites
As recommended in the WHO guide (World Health Organization, The SIGN Alliance,
2001), three large urban districts (based on population size), two sub-urban districts
(Nalaikh, Baganuur) located in Ulaanbaatar known to be representative of all socioeco-
nomic groups in Mongolia were selected. There are three public central hospitals, eight
specialized centres, nine district hospitals, six private hospitals and 126 Family Group
Practices (FGPs) located in Ulaanbaatar (Information and Technology Department of
Ulaanbaatar, 2013). Selection of health facilities was done purposively based on their
location and accessibility. For the study, three public central hospitals in large districts,
three district hospitals in urban and two district hospitals in sub-urban districts, three
private hospitals in sub-urban districts and 20 FGPs located in both large and small
(sub-urban) districts were purposively selected.
A purposive sample of forty community pharmacies was selected from the five districts
to represent a range of pharmacies based on their size, accessibility and distance from
clinics, following discussions with local professionals, and ensuring that no particular
type of pharmacy was excluded. These included 12 of the 22 pharmacies consenting to a
previous study and a further 28 pharmacies were approached (Dorj et al., 2013). In respect
to their location, 25 community pharmacies were located in three large districts and 15
were in two sub-urban districts.
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Doctors working in the above-mentioned health facilities were randomly selected
from the list of actively working employees, provided by human resource offices in the
selected sites. Pharmacists and pharmacy technicians were conveniently selected from the
pharmacies.
Administration of the questionnaires
After obtaining verbal consent, a self-administered questionnaire was distributed by hand
to eligible participants (pharmacist and/or pharmacy technician, doctor and/or specialist)
working in community pharmacies or hospitals in urban and sub-urban districts of
Ulaanbaatar, Mongolia.
In order to improve the response rate, the survey was issued in the early mornings or
when the participants were able to focus on the survey. No more than two respondents
were selected from the same pharmacy or clinic and where there were two, they were a
pharmacist and a pharmacy technician or a doctor and a specialist. Respondents completed
the questionnaire independently, if there were more than one respondent at the same
setting. The questionnaires were collected from pharmacies and clinics by the researcher.
Data analysis
Standard descriptive statistics were used to summarize demographic data and responses to
the questionnaires. Questions regarding the frequency of dispensed/prescribed medicines
for the treatment of CAP were answered using a five-point Likert scale ranging from
never to always. For some analyses, the responses were condensed into three categories
(never/rarely, sometimes, and often/always). Responses using Likert scales that ranged
from strongly agree to strongly disagree were similarly formed into two groups, strongly
agree/agree, and disagree/strongly disagree. For other analyses, the Likert scale responses
were coded from one to five, so that mean scores and standard deviations could be
calculated and used to compare differences between groups.
The mean values of responses measured on a Likert scale may be assumed to be
normally distributed, as the number of respondents was large (>30) in each group,
pharmacy and pharmacy technicians-(61), doctors-(71) (Central Limit Theorem)
(Lumley et al., 2002).
Comparisons between groups based on route of administration (injection versus
oral/other), setting (private versus public) and professional level (pharmacist versus
pharmacy technician) were performed using the Chi-square test, logistic regression or
Kruskal–Wallis test with a pairwise comparison as appropriate. A p value of <0.05 was
taken as indicating a statistically significant difference.
Ethical considerations and confidentiality
The study protocol was approved by the Human Research Ethics Committee, Curtin
University, Western Australia (PH-11-2010). The questionnaire study was completed
during January until May, 2010.
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Data accessibility and sharing
Extra data are available by emailing the corresponding author (GD).
RESULTS
Questionnaires were distributed to 45 pharmacists and 35 pharmacy technicians (n = 80).
An overall response of 61 (76.3%) completed survey forms were returned from the
‘pharmacy group.’ Pharmacists (11) and pharmacy technicians (8) who did not consent
were working in pharmacies located in the large districts. The refusal was due to busy
workload and unwillingness to participate.
A majority of respondents was female (77.0%), and most were aged between 31 and
50 years. A little over half were pharmacists (55.7%), and most respondents had been
working for one to five years (65.6%). The study included one pharmacist, and/or
pharmacy technician from each pharmacy and accordingly they were visited in their
working area. Where the two were at the same pharmacy, they completed the questionnaire
independently.
In addition, questionnaires were distributed to 80 doctors of whom 35 were general
practitioners (GPs) and 45 were medical specialists. The response rate was 88.8% (71/80)
and 83.1% were female doctors, which is comparable to the gender distribution of all
doctors in Mongolia (79.1%) (Ariuntuya et al., 2011). Most respondents were working
in public hospitals and about 70% were specialists. A majority was over 30 years of age
(63.4%) with a monthly income of over 300.000 MNT (Mongolian National Tugrug,
currency, 100 USD is equivalent to 130,000 MNT at the time of study) (Table 1).
Pharmacists and pharmacy technicians reported that injections were prescribed and
dispensed for the treatment of mild/moderate CAP. Commonly prescribed antibiotics that
were dispensed were ampicillin injections (52.5%), injectable cefalosporins (75.4%) and
injectable quinolones (55.7%). These were more frequently dispensed than the oral forms.
Oral macrolides (50.8%) were dispensed more frequently than an injection (Table 2).
According to the current regulations, only qualified medical doctors can prescribe pre-
scription medicines approved by the order of the Minister of Health to patients (Ministry
of Health Mongolia, 2010). However, the provision of over the counter (OTC) medicines,
including injections occurs in Mongolian pharmacies (Margaret, 2011; Tsolmongerel et
al., 2013). Pharmacists and pharmacy technicians were asked to indicate their practice of
providing OTC antibiotics for the treatment of CAP. Most reported they never or rarely
provided OTC medicines (65.0%); on the other hand 13 pharmacists and pharmacy
technicians (21.7%) provided OTC antibiotics sometimes. However, when presented with
questions related to medicines that were provided OTC, the respondents indicated a higher
frequency of commonly provided OTC antibiotics, for example: injectable penicillins
with extended spectrum (e.g., ampicillin) (36.1%). Additionally, respondents indicated
that OTC injectable (37.7%) and oral cefalosporins (31.1%) were frequently provided. In
contrast, injectable macrolides were less frequently provided (10.9%) (Table 2).
Other medicines dispensed with a prescription for the treatment of CAP included
mucolytics (50.8%), oral vitamins (38.7%) and oral antihistamines (21%). Additionally,
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Table 1 Demographic characteristics of respondents.
Variablea Category Pharmacists
and pharmacy technicians
(N = 61) n (%)
Doctors (N = 71)
n (%)
Age (years) 20–30 22 (36.1) 26 (36.6)
31–50 23 (37.7) 45 (63.4)c
≥51 16 (26.2)
Gender Male 14 (23.0) 12 (16.9)
Female 47 (77.0) 59 (83.1)




49 (80.3) 17 (23.9)
Professional level Pharmacist General doctor 34 (55.7) 22 (31.0)
Pharmacy technician Specialist 27 (44.3) 49 (69.0)
Years of working experience 1–5 40 (65.6) 34 (47.9)
6–10 11 (18.0) 12 (16.9)
≥11 10 (16.4) 25 (35.2)
Monthly income (MNT)b 90.000–200.000 9 (15.0) 12 (17.1)
201.000–300.000 13 (21.7) 28 (40.0)
≥301.000–400.000 23 (38.3) 30 (42.9)d
≥401.000 15 (25.0)
Notes.
a Some responses were missing for each category.
b Mongolian National Tugrug, (MNT), currency, 100 USD was equivalent to 130,000 MNT at the time of study.
c The number represents respondents aged ≥31 years old.
d The number represents respondents with a monthly income of ≥301.000 MNT and higher.
injectable corticosteroids (29.5%) and injectable xanthins (22.0%) were frequently
dispensed non-antibiotics (Table 3). There was also some provision of oral or injectable
non-antibiotic OTC medicines from pharmacies with regards to corticosteroids (about
10%) and pyrazolones (13%). Again, similar to the medicines dispensed with a prescrip-
tion, the most common OTC medicines provided for treatment of CAP were oral vitamins
and oral xanthins (Table 3).
In order to gain an understanding the underlying reasons for prescribing and providing
OTC injections, respondents were asked to indicate the extent to which they agreed with
issues that influenced their provision practice of OTC medicines (Table 4).
Most respondents commonly reported that injections were provided if patients had
severe CAP (pharmacists and pharmacy technicians (79.3%), doctors (47.9%)). A majority
of pharmacists and pharmacy technicians strongly agreed that injections were provided
OTC to achieve better patient compliance with treatment (68.4%), however this reason was
supported by only eleven doctors (15%). Male doctors tended to agree more than females
with injections improving patient compliance with a treatment regimen (p = 0.011, (male
M = 3.0, STD = 1.17, f: M = 2.0, STD = 0.9)).
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Table 2 Questionnaire percentage frequencies of antibiotics dispensed with prescription or provided OTC for treatment of CAP, orally and injection
by pharmacists and pharmacy technicians (N = 61).













Aminopenicillins, oral 77 (31.6) 70 (28.7) 97 (39.8) 79 (32.4) 73 (29.9) 92 (37.7)
Aminopenicillins, injection 55 (30.1) 51 (27.9) 77 (27.9) 77 (42.1) 44 (24.0) 62 (33.9)
Quinolone, oral 53 (43.4) 28 (23.0) 41 (33.6) 67 (54.9) 30 (24.6) 25 (20.5)
Quinolone, injection 13 (21.3) 14 (23.0) 34 (55.7) 30 (49.2) 13 (21.3) 18 (29.5)
Cefalosporin, oral 16 (26.2) 15 (24.6) 30 (49.2) 28 (45.9) 14 (23.0) 19 (31.1)
Cefalosporin, injection 7 (1.5) 8 (13.1) 46 (75.4) 28 (45.9) 10 (16.4) 23 (37.7)
Macrolides, oral 40 (21.9) 50 (27.3) 93 (50.8) 77 (42.1) 53 (29.0) 53 (29.0)
Macrolides, injection 131 (71.6) 26 (14.2) 26 (14.2) 134 (73.2) 29 (15.8) 20 (10.9)
Tetracycline, oral 103 (84.4) 16 (13.1) 3 (2.5) 91 (74.6) 19 (15.6) 12 (9.8)
Sulfonamid, oral 18 (29.5) 19 (31.1) 24 (39.3) 17 (27.9) 18 (29.5) 26 (42.6)
Notes.
a Some responses were missing for each category.
b Respondents could choose more than option.
Table 3 Frequencies of non-antibiotic medicines dispensed with prescription and provided OTC for treatment of CAP, by pharmacists and pharmacy
technicians (N = 61).













Corticosteroid, oral 31 (50.8) 19 (31.1) 11 (18.0) 35 (59.3) 16 (27.1) 8 (13.6)
Corticosteroid, injection 19 (31.1) 24 (39.3) 18 (29.5) 28 (48.3) 24 (41.4) 6 (10.3)
Vitamin, oral 31 (26.1) 42 (35.3) 46 (38.7) 28 (23.7) 30 (25.4) 60 (50.8)
Vitamin, injection 88 (49.4) 56 (31.5) 34 (19.1) 97 (55.1) 42 (23.9) 37 (21.0)
Antihistamin, oral 58 (48.7) 36 (30.3) 25 (21.0) 63 (53.4) 24 (20.3) 31 (26.3)
Antihistamin, injection 37 (62.7) 15 (25.4) 7 (11.9) 41 (70.7) 11 (19.0) 6 (10.3)
Xanthin,c oral 18 (30.0) 25 (41.7) 17 (28.3) 21 (35.0) 15 (25.0) 24 (40.0)
Xanthin, injection 27 (45.8) 19 (32.2) 13 (22.0) 34 (57.6) 12 (20.3) 13 (22.0)
Pyrazolone, oral 45 (76.3) 7 (11.9) 7 (11.9) 35 (60.3) 13 (22.4) 10 (17.2)
Pyrazolone, injection 44 (75.9) 9 (15.5) 5 (8.6) 37 (63.8) 13 (22.4) 8 (13.8)
Notes.
a Some responses were missing for each category.
b Respondents could choose more than option.
c Xanthin is euphyllin.
Amongst respondents, a fairly high proportion of pharmacists and pharmacy techni-
cians (69%) and 44% of doctors specified that the clinical effect of injections was better
than oral medicines. No significant relationship was observed between pharmacists and
pharmacy technicians (p = 0.59). Additionally, the proportion of pharmacists supporting
the idea that medication outcomes from injections were better than tablets or capsules
tended to be greater (62.5%) than pharmacy technicians (53.8%), yet it was not statistically
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Table 4 Percentage frequencies of characteristics that influence the practice of providing medicines and prescribing for the treatment of CAP.
Characteristica Pharmacists and pharmacy
technicians (N = 61)
Doctors (N = 71)






The clinical effect of injections is more potent
than oral medicines’
14 (24.1) 40 (68.9) 4 (6.9) 16 (22.5) 24 (33.8) 31 (43.7)
The pharmaceutical quality of injections is better
than tablets/capsules
17 (29.3) 34 (58.6) 7 (12.1) 15 (21.1) 27 (38.0) 29 (40.8)
Adverse events occur with oral drugs more than
with injections
32 (55.2) 16 (27.6) 10 (17.2) 39 (54.9) 22 (31.0) 10 (14.1)
The dosage form of injection is chosen for better
compliance of a patient
9 (15.8) 39 (68.4) 9 (15.8) 34 (47.9) 6 (36.6) 11 (15.5)
The injection requires new syringes and needles 8 (13.8) 48 (82.8) 2 (3.4) 2 (2.8) 7 (9.9) 62 (87.3)
Training promotes more about treatment with an
injection than oral medicines
38 (65.5) 12 (20.7) 8 (13.8) 52 (73.2) 15 (21.1) 4 (5.6)
There is lot of advertisement about injections by
drug companies
38 (65.5) 11 (19.0) 9 (15.5) 35 (49.3) 27 (38.0) 9 (12.7)
Cost of treatment by oral medicines is more than
the treatment cost with injections (including cost
of syringes and needles)
31 (56.9) 21 (36.2) 4 (6.9) 45 (63.4) 11 (15.5) 15 (21.1)
If patients are prescribed an injection, they are
required to visit a pharmacy/hospital several times
32 (55.1) 23 (39.7) 3 (5.2) 8 (11.2) 19 (26.8) 44 (62.0)
Patients prefer to use tablets rather than injection 35 (60.3) 17 (29.3) 6 (10.3) 30 (42.3) 24 (33.8) 17 (23.9)
When dispensing injections, patient’s age, gender
are important
10 (17.2) 44 (75.9) 4 (6.9) 8 (11.3) 16 (22.5) 47 (66.2)
Injection is chosen if patient had severe CAP 10 (17.2) 46 (79.3) 2 (3.4) 16 (22.5) 21 (29.6) 34 (47.9)
Notes.
SA, Strongly agree; A, Agree; D, Disagree; SD, Strongly disagree; NR, No response.
a Some responses were missing for each category.
significant: (p = 0.51). Most pharmacists, including pharmacy technicians (59%) and
some doctors (41%) stated that the pharmaceutical quality of injections was better than
oral medicines.
About 70% of pharmacists including pharmacy technicians did not support the view
that adverse effects occurred more with oral medications than with therapeutic injections.
Similarly, only 14% of doctors agreed that the prevalence of side effects was lower with
injections than with oral medicines. In addition, 21 pharmacists and pharmacy technicians
(36.2%) strongly agreed/agreed that the cost of treatment with injections was higher than
with oral medicines. However, only 15 doctors (21%) supported this.
A similar number of doctors (29%) and pharmacists plus pharmacy technicians
(23.9%) supported the statement that patients preferred oral medicines over injections
(Table 4).
DISCUSSION
This study was undertaken to quantitate the levels injection prescribing by doctors and
provision OTC by community pharmacies from their perspectives, for the treatment of
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mild/moderate CAP in Mongolia. Importantly it has identified some factors influencing
the prescribing of injections which could lead to interventions to improve the underlying
quality of prescribing and reduce that public health hazards associated with the adminis-
tration of injections.
Pharmacists and pharmacy technicians indicated that only 21.7% provided OTC
antibiotics sometimes. However, the frequency of OTC injectable antibiotics provided
was reported as higher elsewhere in the same questionnaire, possibly better indicating
real practice when compared with previous findings (Dorj, Sunderland & Hendrie,
2014). Oral and injectable aminopenicillins (ampicillin or amoxicillin) were commonly
prescribed (Dorj et al., 2013) and this was confirmed by the questionnaire study with
pharmacists, including pharmacy technicians and doctors. This practice was in compliance
with the guidelines (Agvaandorj et al., 2005). However, the guidelines allow for only oral
aminopenicillins for adult and pediatric patients yet 27.9% of prescribing were injections.
Pharmacists and pharmacy technicians indicated a higher likelihood of supplying OTC
oral or injectable aminopenicillins (37.7% versus 33.9%). Cefalosporins were prescribed
for patients with mild pneumonia and doctors tended to prescribe injectable cefalosporins
(cefazolin) rather than oral, and this was supported by the questionnaire study with
pharmacists and pharmacy technicians. OTC sales of cefazolin were also reported in the
questionnaire study, but the pharmacists and pharmacy technicians did not indicate any
preference for either of the dosage forms.
The range of non-antibiotic medicines prescribed for patients with mild/moderate
CAP included vitamins, mucolytics, corticosteroids and antihistamines (Dorj et al.,
2013). However, the prescription results showed that only four injectable vitamins were
prescribed. This is in contrast to the questionnaire studies where doctors indicated a higher
frequency of prescribed injectable vitamins (25.8%) often/always for patients with mild
CAP. The practice of selling by pharmacies of injectable vitamins OTC was also found to be
at a similar level (21%). The practice of providing vitamin injections OTC is not consistent
with current STGs. Detailed results from a previously reported prescription analysis (Dorj
et al., 2013) and these questionnaire studies showed that vitamin C was frequently
prescribed and dispensed for the treatment of mild/moderate CAP. This could reflect a
low fresh food intake containing necessary vitamins, leading to micronutrient deficiencies
in Mongolia (Kachondham et al., 1992; Lander et al., 2008). A Cochrane review of five
trials suggested vitamin C was beneficial in both prevention and treatment of pneumonia.
However, caution must be exercised with generalizations made from trials owing to the
conditions in which the trials were conducted. But for patients who have low plasma
vitamin C levels, intake of vitamin C would be beneficial (Hemilä & Louhiala, 2007).
The questionnaire studies with doctors and pharmacists including pharmacy techni-
cians indicated that they chose an injection if the patient was severely ill. This perspective
is consistent with guidelines and several findings from other countries (Chowdhury et
al., 2011; McIntosh, 2002; Vong et al., 2005). Likewise, considering the period of study
(cold winter) and risk of deterioration of the patient, this practice may reflect clinical
concern. However, choosing an injection for adult patients with mild/moderate CAP is
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non-compliant with current STGs (Agvaandorj et al., 2008; Mongolian National Center for
Standardization and Metrology, 2008).
Financial considerations are another important reason why injections were preferred
by prescribers and providers. In this study most respondents acknowledged that the cost
of treatment with injections was higher than with oral medicines. Economic incentives
from prescribing an injection were reported in a previous study where 19% of high rate
injection prescribers admitted having economic incentives for prescribing injections in
Iran (Ismaeilzadeh, Nikfar & Rahimi, 2006). The large number of doctors on a population
basis practising in Mongolia maybe a potential factor for doctors to seek additional
income sources.
Additionally, one of the factors that contributed to the inappropriate use of injections
in developing countries has been the prescriber’s perception that patients preferred
them (Hutin, Hauri & Armstrong, 2003; McIntosh, 2002; Vong et al., 2005; Ismaeilzadeh,
Nikfar & Rahimi, 2006; Hadiyono et al., 1996). In this study, approximately 24% of
doctors and 29% of pharmacists, plus pharmacy technicians strongly supported the
notion that patients often/always preferred oral medications. This is contrasted with
findings that only 16% of community members always/often expected injections to
be prescribed (Srinivasan, 2004). A previous research study that investigated maternal
perception of mild pneumonia in an outpatient clinic found that 40% of mothers stated
doctors should give their child at least one injection. However, the generalization of that
report to a larger population might be questionable, due to a small number and poor
understanding of the participants (n = 50) (Malik Kundi et al., 1993). Other literature
has confirmed that injections were often not preferred by patients, when they were
advised about the clinical efficacy and potential risks associated with unsafe injection
practices (Hadiyono et al., 1996). Health workers in developing countries believed that
patient’s compliance was better with injections than with oral medication (Michelle, 2004;
AnneLoes van & Anita, 1996) and similarly, some doctors and particularly pharmacists in
this study have indicated choosing an injection was to avoid non-compliance problems.
Limitations
The reliability of the study results involved a triangulation method, matching the
prescription data from an earlier report with questionnaire responses from doctors,
pharmacists and pharmacy technicians (Dorj et al., 2013). Despite the strengths of
this study, some methodological aspects must be considered when interpreting results.
Firstly, the selection of pharmacists and pharmacy technicians was based on a purposive
selection of 40 community pharmacies. Also, the relatively small number of samples of
health settings (eleven hospitals and 20 FGPs located in Ulaanbaatar city) may lead to
selection bias and imprecise estimates. However, the high response rate of respondents in
the questionnaire studies (pharmacists and pharmacy technicians (76%), doctors (89%))
was likely to avoid significant responder bias. In addition, the doctors were recruited
randomly from the list provided by the human resource department of each hospital. This
study recruited more specialists than general doctors, suggesting that the results may be
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more generalizable to them. However, the study included twenty-two general doctors, also
providing information about their treatment of mild/moderate CAP patients.
In addition, the issue of compliance was only addressed in terms of whether it was
an overall factor influencing the prescribing of injections over oral preparations which
is the only dosage form recommended for adults. Compliance is a complex issue for
children as an injectable product (gentamicin) is included in the STGs for children. From
a compliance perspective for children, there is a range of factors influencing compliance
dependent on the child’s age and parental involvement and whether it is compliant with the
daily dosing schedule or the duration of the antibiotic or both. Hence, this was too complex
an issue to address fully in this study.
CONCLUSION
Non-compliance with STGs in respect to prescribing injections for mild/moderate
CAP was evident in Mongolia. In addition, the high prevalence of the prescribing of
non-antibiotic injections was inappropriate for mild/moderate CAP. The supply of
antibiotic injections OTC from pharmacies, although currently indicating a similar range
of selections being made to those prescribed by physicians, should be ceased unless this
would markedly reduce access to treatment for poorer patients. Additional measures need
to be put in place with the aim of reducing the high level of inappropriate injections
prescribed in Mongolia. It is notable that the current standard treatment guidelines are
followed by less than 40% of prescribers in Mongolia.
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